バイオニックアイ市場 - 世界の産業規模、シェア、動向、機会、予測：タイプ別、エンドユーザー別、地域別、競合、2020年～2030年

バイオニックアイの世界市場は、2024年には3億2,215万米ドルとなり、2030年には6億1,209万米ドルに達する見込みで、予測期間中のCAGRで11.25%の成長が予測されています。

この新興分野は、バイオテクノロジー、人工知能、神経工学の進歩により、医療機器と神経補綴の技術革新の最前線にあります。バイオニックアイは、網膜インプラントからブレインマシンインターフェース（BMI）に至るまで、重度の視覚障害や永久的な失明に苦しむ人々の部分的な視力回復を目指しています。技術の高度化、臨床研究の拡大、難治性視力喪失の有病率の上昇が、市場の加速に寄与しています。AI主導の画像処理、ワイヤレス接続、機械学習の統合は、機器の性能とユーザーの成果をさらに向上させています。臨床範囲が網膜疾患からより広範な神経障害に拡大するにつれて、バイオニックアイ市場は患者への影響と商業的機会の両方において変革的な成長を遂げる態勢が整っています。

市場促進要因

視力喪失と治療不可能な失明の有病率の上昇

主な市場課題

高い開発・展開コスト

主な市場動向

ブレインマシンインターフェース（BMI）と神経補綴の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 バイオニックアイ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（外眼部、移植眼）
  • エンドユーザー別（病院、外来施設、研究・製造）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米のバイオニックアイ市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のバイオニックアイ市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域のバイオニックアイ市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のバイオニックアイ市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのバイオニックアイ市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界のバイオニックアイ市場：SWOT分析

第14章 競合情勢

• Second Sight Medical Products LLC
• Nidek Co. Ltd.
• Nano Retina Ltd.
• MetaModal LLC
• Biomedical Technologies S.L.
• Bionic Vision Technologies
• Pixium Vision
• Monash Vision Group

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Bionic Eye Market was valued at USD 322.15 Million in 2024 and is projected to reach USD 612.09 Million by 2030, growing at a CAGR of 11.25% during the forecast period. This emerging sector is at the forefront of medical device and neuroprosthetics innovation, driven by advances in biotechnology, artificial intelligence, and neural engineering. Bionic eyes-ranging from retinal implants to brain-machine interfaces-aim to restore partial vision in individuals suffering from profound visual impairment or permanent blindness. Increasing technological sophistication, expanding clinical research, and rising prevalence of incurable vision loss are all contributing to the market's acceleration. The integration of AI-driven imaging, wireless connectivity, and machine learning is further enhancing device performance and user outcomes. As the clinical scope extends from retinal conditions to broader neurological impairments, the bionic eye market is poised for transformative growth in both patient impact and commercial opportunity.

Key Market Drivers

Rising Prevalence of Vision Loss and Untreatable Blindness

The increasing incidence of irreversible vision loss due to inherited retinal diseases, age-related macular degeneration (AMD), glaucoma, and optic nerve atrophy is a primary factor fueling demand for bionic eye systems. These conditions frequently progress to stages where existing treatments-such as medications, surgeries, or laser therapies-fail to preserve or restore sight. Globally, more than 1.5 million individuals are affected by hereditary retinal disorders, and approximately 43 million people were estimated to be completely blind in 2020. With aging populations and lifestyle-related health risks such as diabetes on the rise, the global burden of blindness is expected to increase. Bionic eye technologies, including retinal prostheses and neural implants, provide an alternative approach by transmitting visual data directly to the brain or bypassing damaged retinal cells. For patients who no longer respond to conventional therapies, these systems represent a critical solution, filling a treatment void and offering new hope for functional visual recovery.

Key Market Challenges

High Development and Deployment Costs

The complexity of bionic eye systems-requiring cutting-edge microelectronics, neurosensory interfaces, and high-precision surgical procedures-results in substantial development and operational costs. Total treatment costs, including device implantation, patient rehabilitation, and post-operative support, often place the technology beyond the reach of many healthcare providers and patients, particularly in low- and middle-income regions. Limited insurance reimbursement further hinders accessibility. This cost barrier has slowed the pace of adoption and restricted market entry primarily to specialized centers in high-income countries, impeding broader market penetration.

Key Market Trends

Advancements in Brain-Machine Interface (BMI) and Neuroprosthetics

A transformative trend in the bionic eye market is the integration of brain-machine interface technologies, which allow direct communication between external image sensors and the visual cortex. This bypasses damaged optic nerves or retinal pathways, enabling potential restoration of higher-order visual functions such as object identification and spatial awareness. Innovations in electrode array design, neural decoding algorithms, and bio-compatible materials are supporting the development of more natural and responsive visual systems. As these advancements gain traction, next-generation bionic eye devices are evolving beyond basic light detection to provide richer, more functional visual experiences-attracting growing interest from researchers, investors, and medical institutions.

Key Market Players

• Second Sight Medical Products LLC
• Nidek Co. Ltd.
• Nano Retina Ltd.
• MetaModal LLC
• Biomedical Technologies S.L.
• Bionic Vision Technologies
• Pixium Vision
• Monash Vision Group

Report Scope:

In this report, the Global Bionic Eye Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bionic Eye Market, By Type:

• External Eye
• Implanted Eye

Bionic Eye Market, By End User:

• Hospitals
• Outpatient Facilities
• Research and Manufacturing

Bionic Eye Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bionic Eye Market.

Available Customizations:

Global Bionic Eye market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Bionic Eye Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (External Eye, Implanted Eye)
  • 5.2.2. By End User (Hospitals, Outpatient Facilities, Research and Manufacturing)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Bionic Eye Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Bionic Eye Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Bionic Eye Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Bionic Eye Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End User

7. Europe Bionic Eye Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Bionic Eye Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End User
  • 7.3.2. United Kingdom Bionic Eye Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End User
  • 7.3.3. Italy Bionic Eye Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End User
  • 7.3.4. France Bionic Eye Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Bionic Eye Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By End User

8. Asia-Pacific Bionic Eye Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Bionic Eye Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End User
  • 8.3.2. India Bionic Eye Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Bionic Eye Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Bionic Eye Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Bionic Eye Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By End User

9. South America Bionic Eye Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Bionic Eye Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Bionic Eye Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Bionic Eye Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End User

10. Middle East and Africa Bionic Eye Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Bionic Eye Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Bionic Eye Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Bionic Eye Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Bionic Eye Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Second Sight Medical Products LLC
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Nidek Co. Ltd.
• 14.3. Nano Retina Ltd.
• 14.4. MetaModal LLC
• 14.5. Biomedical Technologies S.L.
• 14.6. Bionic Vision Technologies
• 14.7. Pixium Vision
• 14.8. Monash Vision Group

15. Strategic Recommendations

16. About Us & Disclaimer